請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/618
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李茂生(Mau-Sheng Lee) | |
dc.contributor.author | Ying-Chieh Lin | en |
dc.contributor.author | 林英杰 | zh_TW |
dc.date.accessioned | 2021-05-11T04:44:57Z | - |
dc.date.available | 2020-02-19 | |
dc.date.available | 2021-05-11T04:44:57Z | - |
dc.date.copyright | 2020-02-19 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2020-02-13 | |
dc.identifier.citation | [1] 趙欣,趙迎澤。(2016)。對話周琪:華盛頓共識 科學通報, 61 (3) : 283-284.
[2] 紀十。(2017年03月27日),基因編輯的倫理邊界在哪裡? [3] 人體基因編輯倫理爭議?再生醫學聯盟(ARM)提五大原則( GeneOnline 2019) [4] 王澤榮。(2018年12月11日),中國對「基因編輯」的規範邊界在哪? [5] 蔡宗珍。(2001年07月)。「基因科技安全管制法」草案總說明。生物科技與法律研究通訊,11期,16~18頁。 [6] 胡務亮。(2004年06月)。衛教百科,科學發展,378期。 [7] 中國複製猴:繼承桃莉羊,「中中」「華華」的爭議誕生。(2018年01月25日)。取自:https://global.udn.com/global_vision/story/8662/2949560 [8] 研究證實複製人類非常危險。(2017年01月24日)。取自:https://kknews.cc/ science/jvnzvey.html [9] 桃莉羊出現後20年,複製動物技術改變了什麼?(2016年12月29日)。取自:https://kknews.cc/zh-tw/science/n56p9rq.html [10] 醫學治療的新境界:基因療法的過去、現在與未來。(2017年12月12日)。取自:https://geneonline.news/index.php/2017/12/12/gene-therapy-past-now- future/ [11] 寒波,(2019年02月04日),為何基因改造人類很母湯?實驗設計還不如研究生——賀建奎基因編輯嬰兒事件(上),泛科學。 [12] 寒波,(2019年02月04日),為何基因改造人類很母湯?實驗設計還不如研究生——賀建奎基因編輯嬰兒事件(下),泛科學。 [13] Gaj, T., Gersbach, C. A., & Barbas, C. F., 3rd (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in biotechnology, 31(7), 397–405. [14] Jim Lucas, (2014, September. 25), What Is Biomedical Engineering? Live Science, Retrieved [15] What is gene therapy? National Library of Medicine [16] Ernest Beutler, (2001), The cline affair, Molecular Therapy, 4(5), 396~397 [17] R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Charles S. Carter, Thomas Fleisher, Mario Clerici, Gene Shearer, Lauren Chang, Yawen Chiang, Paul Tolstoshev, Jay J. Greenblatt, Steven A. Rosenberg, Harvey Klein, Melvin Berger, Craig A. Mullen, W. Jay Ramsey, Linda Muul, Richard A. Morgan, W. French Anderson, (1995), T Lymphocyte Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years, Science, 270(5235) : 475-480 [18] Edward H. Oldfield, (1993), Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health, Human Gene Therapy, 4(1), [19] Albert M. Maguire, M.D., Francesca Simonelli, M.D., Eric A. Pierce, M.D., Ph.D., Edward N. Pugh, Jr., Ph.D., Federico Mingozzi, Ph.D., Jeannette Bennicelli, Ph.D., Sandro Banfi, M.D., Kathleen A. Marshall, C.O.T., Francesco Testa, M.D., Enrico M. Surace, D.V.M., Settimio Rossi, M.D., Arkady Lyubarsky, Ph.D., et al., (2008), Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis, The New England Journal of Medicine, 358, 2240-2248 [20] Ewen Callaway, (2008, April 28), Gene therapy success 'reverses' blindness ,New Science, [21] Alain Fischer, Salima Hacein-Bey-Abina & Marina Cavazzana-Calvo, (2010), 20 years of gene therapy for SCID, Nature Immunology, 11(6), 457-460, doi:10.1038/ni0610-457 [22] Adenosine deaminase deficiency., National Library of Medicine [23] Francesca Ferrua, Immacolata Brigida, Alessandro Aiuti, (2010), Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency, Allergy and Clinical Immunology., 10(6):551–556 [24] Nathalie Cartier, Patrick Aubourg, (2010), Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X‐Linked Adrenoleukodystrophy, Brain Pathology [25] Heidi Ledford, (2011, August 10), Cell therapy fights leukaemia, Nature, [26] Andy Coghlan, (2013, March 26), Gene therapy cures leukaemia in eight days, New Science, [27] Andy Coghlan, (2012, December 11), Souped-up immune cells force leukaemia into remission, New Science [28] How does gene therapy work? National Library of Medicine [29] Francis S. Collins., (2015.04.29). Statement on NIH funding of research using gene-editing technologies in human embryos. [30] Michelle Ralston ,(2008, July.17), Stem Cell Research Around the World ,The Pew Forum on Religion & Public Life [31] Termination of pregnancies, The 2018 Florida Statutes, 390.0111 [32] Human Fertilisation and Embryology UK Act 2008, (Signed 1990, Ratified2008) [33] Thomas Wirth, Nigel Parker, Seppo Ylä-Herttuala, (2013), History of gene therapy, Gene, 525(2), 162-169 [34] Convention for the Protection of Human Rights and Dignity of the Human ETS164, Oviedo, 4.IV.1997 (Signed 1997, April.4, Ratified 1999, December.1) [35] Lynch VJ, Bedoya-Reina OC, Ratan A, Sulak M, Drautz-Moses DI, Perry GH, Miller W, Schuster SC., (2015), Elephantid Genomes Reveal the Molecular Bases of Woolly Mammoth Adaptations to the Arctic., Cell Report, 12(2), 217-228, [36] David Shultz, (2016, September 26), Should we bring extinct species back from the dead? Science [37] Christopher J. Preston, (2017), De‐extinction and Taking Control of Earth’s “Metabolism”, Hastings Center Report, 47(2), 37-42, doi: https://doi.org/10.1002/hast.750 [38] Cafer Adiguzel, Omer Iqbal, Muzaffer Demir, Jawed Fareed, (2009), European Community and US-FDA Approval of Recombinant Human Antithrombin Produced in Genetically Altered Goats, Clinical and Applied Thrombosis/Hemostasis,15(6), 645-651, doi: [39] Isao Oishi, Kyoko Yoshii, Daichi Miyahara, Hiroshi Kagami & Takahiro Tagami (2016), Targeted mutagenesis in chicken using CRISPR/Cas9 system, Scientific Reports, 6, doi: [40] Buchthal, J., Evans, S. W., Lunshof, J., Telford, S. R., 3rd, & Esvelt, K. M. (2019). Mice Against Ticks: an experimental community-guided effort to prevent tick-borne disease by altering the shared environment. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 374(1772) [41] Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM, Bier E, James AA , (2015), Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi., Proc Natl Acad Sci U S A., 112(49) [42] Andrew Hammond, Roberto Galizi, Kyros Kyrou, Alekos Simoni, Carla Siniscalchi, Dimitris Katsanos, Matthew Gribble, Dean Baker, Eric Marois, Steven Russell, Austin Burt, Nikolai Windbichler, Andrea Crisanti & Tony Nolan, (2016), A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae, Nature Biotechnology, 34, 78–83 [43] Jocelyn Kaiser, (2018), Gene edited monkeys offer hope for heart disease patients, Science, [44] Ian Sample, (2018), Sex-change mice research could help humans, say scientists, The Guardian [45] James Gallagher, (2018, June 14), Gene therapy reverses rat's paralysis, Health and science correspondent, BBC News, Retrieved from: https://www.bbc.com/news/ health-44484901 [46] Henry Bodkin, (2018, March 30), Huntington's disease pigs created in hope of gene editing breakthrough, Science [47] Sen Yan, Zhuchi Tu, Zhaoming Liu, Nana Fan, Huiming Yang, Su Yang, Weili Yang, Yu Zhao, Zhen Ouyang, Chengdan Lai, Huaqiang Yang, Li Li, Qishuai Liu, Hui Shi, Guangqing Xu, Heng Zhao, Hongjiang Wei, Zhong Pei, Shihua Li, Liangxue Lai, Xiao-Jiang Li, (2018), A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington’s Disease, 173(4), 989-1002, doi: https://doi.org/10.1016/j.cell.2018.03.005 [48] Human Primary cell, ATCC, Retrieved from: https://www.atcc.org/Products/ Cells_and_Microorganisms/Human_Primary_Cells.aspx [49] Cho SW, Lee J, Carroll D, Kim JS, Lee J., (2013), Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics, 195(3):1177-80., doi: 10.1534/genetics.113.155853. [50] Behnom Farboud, Erin Jarvis, Theodore L. Roth, Jiyung Shin, Jacob E. Corn, Alexander Marson, Barbara J. Meyer, Nipam H. Patel, Megan L. Hochstrasser, (2018), Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms, Journal of Visualized Experiments, (135), e57350 doi: 10.3791/57350 [51] Mariynn Marchione, (2018, November 26), Rice University investigates professor's involvement in genomic editing of human embryos, Click2houston [52] Paul Knoepfler, (2018), Gene editing: sloppy definitions mislead, Nature 564, 345, doi: 10.1038/d41586-018-07802-2 [53] HUGO Ethics Committee - Statement on cloning, (1999) Eubios Journal of Asian and International Bioethics 9,70 [54] Mazhar Adli , (2018), The CRISPR tool kit for genome editing and beyond, Nature Communications, 9 (1911), doi: https://doi.org/10.1038/s41467-018-04252-2 [55] Stephen E Levick, (2014), Were it physically safe, human reproductive cloning would not be acceptable, Contemporary Debates in Bioethics, 73-103 [56] The Constitution of the Republic of South Africa, (1996), South African Government [57] Prohibition of Human Cloning for Reproduction Act 2002 No. 144, (2017, September 21) [58] Human Gene Therapy for Rare Diseases Draft Guidance for Industry, (2018, July), Center for Biologics Evaluation and Research, FDA-2018-D-2258 [59] Constitution of Finland, (2012), Ministry of justice Finland | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/handle/123456789/618 | - |
dc.description.abstract | 醫學與科學的進步,讓號稱神的領域-生命創造,逐一的揭密。其中基因與遺傳物質的研究更是漸漸興起。近幾年發展出的基因編輯,不但引發了人類治療絕症、強化身體的夢想。也帶來了無限商機。
然而,基因編輯意味著用每個生物體可以讓DNA修復或具備有新的功能。但將基因片段取代也可能,創造出人類意料之外的可能性。這樣的科學新技術,將產生許多法律、人權、倫理,以及人類社會未曾有過的問題。尤其現在的法律對這些問題並未能充分解釋。而執法機關也需要專業知識與法源依據來面對這些挑戰。 世界衛生組織也成立了一個基因編輯小組,用以審查人類基因編輯相關的科學、倫理與法律爭議,也建議每一個基因編輯研究必須進行登記,保持研究的透明度。然而無論怎麼管理,基因編輯都會引起倫理上的問題。除了涉及人類倫理,更包含了法律問題。以上的這一個新的領域,不再是管理自然群體中的問題,而是我們開始干預生命、創造與編輯物種,這將是我們成為法律研究人,新一代的挑戰。 因此,在本研究中將試著探討國內外人類基因編輯的管理與法律規範。希望在未來的日子裡,能夠有機會貢獻一些粗淺的想法以供參考。 | zh_TW |
dc.description.abstract | Advances in medicine and science have opened up the realm of life called life creation, one by one. Among them, the study of genes and genetic materials is gradually emerging. The gene editing developed in recent years has not only triggered the human dream of treating terminal illness and strengthening the body. It also brings unlimited business opportunities.
However, gene editing means that each organism can make DNA repair or have new functions. But replacing gene fragments is also possible, creating unexpected possibilities for humans. Such new science and technology will generate many laws, human rights, ethics, and problems that have never been encountered in human society. In particular, the current law does not fully explain these issues. Law enforcement agencies also need expertise and legal basis to face these challenges. The World Health Organization(WHO)has also set up a gene editing team to review scientific, ethical, and legal disputes related to human gene editing. It also recommends that every gene editing study be registered to maintain research transparency. Regardless of how it is managed, however, gene editing raises ethical issues. In addition to human ethics, it also includes legal issues. This new field above is no longer a problem of managing natural groups, but that we begin to interfere in life, create and edit species, and this will be a challenge for us to become a new generation of legal researchers. Therefore, in this study, we will try to explore the management and legal norms of human gene editing at home and abroad. I hope that in the future, I will have the opportunity to contribute some superficial ideas for reference. | en |
dc.description.provenance | Made available in DSpace on 2021-05-11T04:44:57Z (GMT). No. of bitstreams: 1 ntu-108-P06e42017-1.pdf: 1748486 bytes, checksum: 4831a8203ea9d923d990d809489f9474 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii Abstract iv 第一章 緒論 1 第一節 研究動機 1 第二節 基因編輯與倫理醫學探討 3 第二章 生物醫學與基因編輯之簡介 6 第三章 基因治療研究之衍生性問題-基因編輯 10 第一節 基因編輯 10 第二節 基因編輯應用 11 第三節 人體基因編輯應用 14 第四章 目前國內外對於基因治療與編輯相關規範及草案討論 15 第一節 國內外法規介紹 15 第二節 國際規範及草案比較 23 第五章 基因醫療產生的議題及學說看法 27 第一節 生命人權與倫理道德 27 第二節 民間看法 29 第六章 探討基因編輯法規位階與設立規範的可能問題 31 第七章 結論與建議 35 參考文獻 37 | |
dc.language.iso | zh-TW | |
dc.title | 台灣對於人類基因編輯的管理與法律規範研究 | zh_TW |
dc.title | Research on Management and Legal Regulations of Human Gene Editing in Taiwan | en |
dc.date.schoolyear | 108-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 謝煜偉(Yu-Wei Hsieh),黃士軒(SHIH-HSUAN HUANG) | |
dc.subject.keyword | 基因,基因編輯,基因治療,複製人,人造組織與器官,生物技術管制配合架構, | zh_TW |
dc.subject.keyword | Gene,Gene Editing,Gene Therapy,Clone,Artificial Tissues & Organ,Coordinated Framework for Regulation of Biotechnology, | en |
dc.relation.page | 40 | |
dc.identifier.doi | 10.6342/NTU201904101 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2020-02-13 | |
dc.contributor.author-college | 進修推廣學院 | zh_TW |
dc.contributor.author-dept | 事業經營碩士在職學位學程 | zh_TW |
顯示於系所單位: | 事業經營碩士在職學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf | 1.71 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。